Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: the importance of a mutation in the nsP2 gene - PubMed (original) (raw)
. 1997 Feb 3;228(1):74-83.
doi: 10.1006/viro.1996.8364.
Affiliations
- PMID: 9024811
- DOI: 10.1006/viro.1996.8364
Free article
Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: the importance of a mutation in the nsP2 gene
S A Dryga et al. Virology. 1997.
Free article
Abstract
Sindbis virus is a positive strand RNA virus that has provided a valuable model for studying virus structure and replication. It is also being developed as a vector for the expression of heterologous proteins. Many studies with this virus are carried out in cultured BHK cells where infection is usually highly cytopathic and within 1 or 2 days after infection all of the cells are dead. Weiss et al. had established a persistently infected culture of BHK cells by infecting the cells with a virus preparation highly enriched in defective interfering (DI) particles and had isolated an attenuated virus, SIN-1 virus, from the culture [Weiss et al. (1980) J. Virol. 33, 463-474]. SIN-1 virus, free of DI particles, was able to establish a persistent infection in BHK cells. We initiated studies to determine what changes in the genome of the virus were responsible for this phenotype. We describe here the cDNA cloning and sequencing of the 5' terminus and the four nonstructural protein genes from SIN-1 virus. A single coding mutation in the nsP2 gene (a predicted change of Pro-726 --> Ser) produced a virus that was able to establish persistent infection in BHK cells. Additional mutations in the other genes were required to decrease the synthesis of viral RNA to a level similar to that found in cells infected with SIN-1 virus. Incorporation of the nsP2 mutation into a Sindbis virus expression vector led to a higher level of synthesis of the reporter protein, beta-galactosidase, than that obtained with the original Sindbis virus replicon.
Similar articles
- Effects of the nsP2-726 Pro mutation on infectivity and pathogenesis of Sindbis virus derived from a full-length infectious cDNA clone.
Zhu WY, Fu SH, Wang JL, He Y, Tang Q, Liang GD. Zhu WY, et al. Virus Res. 2009 Jun;142(1-2):204-7. doi: 10.1016/j.virusres.2009.01.017. Epub 2009 Feb 7. Virus Res. 2009. PMID: 19428754 - Restriction of a Sindbis virus mutant in BHK cells and relief of the restriction by the addition of adenosine.
Lin YH, Simmonds HA, Stollar V. Lin YH, et al. Virology. 2002 Jan 5;292(1):78-86. doi: 10.1006/viro.2001.1230. Virology. 2002. PMID: 11878910 - Research on basis of reverse genetics system of a Sindbis-like virus XJ-160.
Wu-yang Z, Guo-dong L. Wu-yang Z, et al. Virol J. 2011 Nov 14;8:519. doi: 10.1186/1743-422X-8-519. Virol J. 2011. PMID: 22082202 Free PMC article. Review. - Recombinant Sindbis virus as an expression system for cell biology.
Piper RC, Slot JW, Li G, Stahl PD, James DE. Piper RC, et al. Methods Cell Biol. 1994;43 Pt A:55-78. doi: 10.1016/s0091-679x(08)60598-1. Methods Cell Biol. 1994. PMID: 7529867 Review. No abstract available.
Cited by
- Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.
Minnaert AK, Vanluchene H, Verbeke R, Lentacker I, De Smedt SC, Raemdonck K, Sanders NN, Remaut K. Minnaert AK, et al. Adv Drug Deliv Rev. 2021 Sep;176:113900. doi: 10.1016/j.addr.2021.113900. Epub 2021 Jul 26. Adv Drug Deliv Rev. 2021. PMID: 34324884 Free PMC article. Review. - Radicicol Inhibits Chikungunya Virus Replication by Targeting Nonstructural Protein 2.
Nam S, Ga YJ, Lee JY, Hwang WY, Jung E, Shin JS, Chen W, Choi G, Zhou B, Yeh JY, Go YY. Nam S, et al. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0013521. doi: 10.1128/AAC.00135-21. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33903104 Free PMC article. - Sindbis viral structural protein cytotoxicity on human neuroblastoma cells.
Saito EY, Saito K, Hishiki T, Takenouchi A, Saito T, Sato Y, Terui K, Matsunaga T, Shirasawa H, Yoshida H. Saito EY, et al. Pediatr Surg Int. 2020 Oct;36(10):1173-1180. doi: 10.1007/s00383-020-04719-8. Epub 2020 Jul 21. Pediatr Surg Int. 2020. PMID: 32696122 Free PMC article. - Viral replicons as valuable tools for drug discovery.
Hannemann H. Hannemann H. Drug Discov Today. 2020 Jun;25(6):1026-1033. doi: 10.1016/j.drudis.2020.03.010. Epub 2020 Apr 6. Drug Discov Today. 2020. PMID: 32272194 Free PMC article. Review. - Small Molecule Inhibitors Targeting Chikungunya Virus.
Haese N, Powers J, Streblow DN. Haese N, et al. Curr Top Microbiol Immunol. 2022;435:107-139. doi: 10.1007/82_2020_195. Curr Top Microbiol Immunol. 2022. PMID: 31974761 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources